Tc 99m NC 100668

Drug Profile

Tc 99m NC 100668

Alternative Names: 99mTc-NC100668; NC100668; Tc-99m-NC100668

Latest Information Update: 11 Sep 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator GE Healthcare
  • Class Oligopeptides; Organotechnetium compounds; Radiopharmaceutical diagnostics
  • Mechanism of Action Radionuclide imaging enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Thrombosis

Most Recent Events

  • 11 Sep 2006 No development reported - Phase-II for Thrombosis (diagnosis) in United Kingdom (unspecified route)
  • 16 Apr 2004 Amersham has merged with GE Medical Systems to form GE Healthcare
  • 08 Oct 2002 Phase-II clinical trials in Thrombosis (diagnosis) in United Kingdom (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top